Cargando…
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
OBJECTIVE: The aim of this study is to describe the prevalence of HPV types in invasive cervical cancers in Italy from 1996 to 2008. METHODS: A pooled analysis of the three largest case series typed to date was performed. HPV typing was performed on paraffin-embedded slices. Molecular analyses were...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527181/ https://www.ncbi.nlm.nih.gov/pubmed/23110797 http://dx.doi.org/10.1186/1750-9378-7-26 |
_version_ | 1782253668810096640 |
---|---|
author | Giorgi Rossi, Paolo Sideri, Mario Carozzi, Francesca Maria Vocaturo, Amina Buonaguro, Franco Maria Tornesello, Maria Lina Burroni, Elena Mariani, Luciano Boveri, Sara Zaffina, Leandra Maria Chini, Francesco |
author_facet | Giorgi Rossi, Paolo Sideri, Mario Carozzi, Francesca Maria Vocaturo, Amina Buonaguro, Franco Maria Tornesello, Maria Lina Burroni, Elena Mariani, Luciano Boveri, Sara Zaffina, Leandra Maria Chini, Francesco |
author_sort | Giorgi Rossi, Paolo |
collection | PubMed |
description | OBJECTIVE: The aim of this study is to describe the prevalence of HPV types in invasive cervical cancers in Italy from 1996 to 2008. METHODS: A pooled analysis of the three largest case series typed to date was performed. HPV typing was performed on paraffin-embedded slices. Molecular analyses were performed in four laboratories. Multivariate analyses were performed to test the associations between calendar time, age, and geographical area and the proportion of types 16/18. RESULTS: Out of 574 cancers, 24 (4.2%) were HPV negative. HPV 16 and 18 were responsible for 74.4% (378/508) and 80.3% (49/61) of the squamous cancers and adenocarcinomas, respectively. Other frequent types were 31 (9.5%), 45 (6.4%), and 58 (3.3%) for squamous cancers and 45 (13.3%), 31, 35, and 58 (5.0%) for adenocarcinomas. The proportion of HPV 16 and/or 18 decreased with age (p-value for trend <0.03), while it increased in cancers diagnosed in more recent years (p-value for trend < 0.005). CONCLUSIONS: The impact of HPV 16/18 vaccine on cervical cancer will be greater for early onset cancers. In vaccinated women, screening could be started at an older age without reducing protection. |
format | Online Article Text |
id | pubmed-3527181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35271812012-12-21 HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies Giorgi Rossi, Paolo Sideri, Mario Carozzi, Francesca Maria Vocaturo, Amina Buonaguro, Franco Maria Tornesello, Maria Lina Burroni, Elena Mariani, Luciano Boveri, Sara Zaffina, Leandra Maria Chini, Francesco Infect Agent Cancer Research Article OBJECTIVE: The aim of this study is to describe the prevalence of HPV types in invasive cervical cancers in Italy from 1996 to 2008. METHODS: A pooled analysis of the three largest case series typed to date was performed. HPV typing was performed on paraffin-embedded slices. Molecular analyses were performed in four laboratories. Multivariate analyses were performed to test the associations between calendar time, age, and geographical area and the proportion of types 16/18. RESULTS: Out of 574 cancers, 24 (4.2%) were HPV negative. HPV 16 and 18 were responsible for 74.4% (378/508) and 80.3% (49/61) of the squamous cancers and adenocarcinomas, respectively. Other frequent types were 31 (9.5%), 45 (6.4%), and 58 (3.3%) for squamous cancers and 45 (13.3%), 31, 35, and 58 (5.0%) for adenocarcinomas. The proportion of HPV 16 and/or 18 decreased with age (p-value for trend <0.03), while it increased in cancers diagnosed in more recent years (p-value for trend < 0.005). CONCLUSIONS: The impact of HPV 16/18 vaccine on cervical cancer will be greater for early onset cancers. In vaccinated women, screening could be started at an older age without reducing protection. BioMed Central 2012-10-12 /pmc/articles/PMC3527181/ /pubmed/23110797 http://dx.doi.org/10.1186/1750-9378-7-26 Text en Copyright ©2012 Giorgi Rossi et al.; licensee Biomed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Giorgi Rossi, Paolo Sideri, Mario Carozzi, Francesca Maria Vocaturo, Amina Buonaguro, Franco Maria Tornesello, Maria Lina Burroni, Elena Mariani, Luciano Boveri, Sara Zaffina, Leandra Maria Chini, Francesco HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies |
title | HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies |
title_full | HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies |
title_fullStr | HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies |
title_full_unstemmed | HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies |
title_short | HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies |
title_sort | hpv type distribution in invasive cervical cancers in italy: pooled analysis of three large studies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527181/ https://www.ncbi.nlm.nih.gov/pubmed/23110797 http://dx.doi.org/10.1186/1750-9378-7-26 |
work_keys_str_mv | AT giorgirossipaolo hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT siderimario hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT carozzifrancescamaria hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT vocaturoamina hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT buonagurofrancomaria hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT tornesellomarialina hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT burronielena hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT marianiluciano hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT boverisara hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT zaffinaleandramaria hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies AT chinifrancesco hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies |